Page last updated: 2024-09-02

sch 28080 and 5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine

sch 28080 has been researched along with 5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine in 1 studies

Compound Research Comparison

Studies
(sch 28080)
Trials
(sch 28080)
Recent Studies (post-2010)
(sch 28080)
Studies
(5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine)
Trials
(5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine)
Recent Studies (post-2010) (5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine)
217020505

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abe, K; Gerle, C; Hayashida, K; Khandelia, H; Madapally, HV; Morita, M; Oshima, A; Shigematsu, H; Tanaka, S; Yamagishi, T1

Other Studies

1 other study(ies) available for sch 28080 and 5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine

ArticleYear
Structural Basis for Binding of Potassium-Competitive Acid Blockers to the Gastric Proton Pump.
    Journal of medicinal chemistry, 2022, 06-09, Volume: 65, Issue:11

    Topics: Gastric Acid; Potassium; Proton Pump Inhibitors; Proton Pumps; Stomach

2022